Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report
Abstract Background Anti-IgLON5 antibody-related encephalopathy is a recently discovered and rare autoimmune disease, and its diagnosis and treatment are more challenging than for other autoimmune encephalopathic diseases. Sleep disorder is the most prominent symptom of the disease. It can also pres...
Main Authors: | Yuting Wang, Xiuling Wu, Baoquan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-021-02145-4 |
Similar Items
-
Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder
by: Jasmin El Shazly, et al.
Published: (2021-02-01) -
Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
by: Mette Scheller Nissen, et al.
Published: (2019-10-01) -
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons
by: Matias Ryding, et al.
Published: (2021-04-01) -
Ocular Motor Abnormalities in Anti-IgLON5 Disease
by: Stefan Macher, et al.
Published: (2021-09-01) -
IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
by: Jeong Ho Lim, et al.
Published: (2021-02-01)